Annual Drug Patent Expirations for LAMICTAL+ODT
Lamictal Odt is a drug marketed by Glaxosmithkline Llc and is included in one NDA. It is available from one supplier. There are three patents protecting this drug and one Paragraph IV challenge.
LAMICTAL ODT drug price trends.
Drug patent litigation for LAMICTAL ODT.
This drug has eighteen patent family members in thirteen countries.
The generic ingredient in LAMICTAL ODT is lamotrigine. One supplier is listed for this compound. Additional details are available on the lamotrigine profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
